Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
about
Canada in the face of the 2009 H1N1 pandemic.How to minimize the attack rate during multiple influenza outbreaks in a heterogeneous population.Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics.Computational assay of H7N9 influenza neuraminidase reveals R292K mutation reduces drug binding affinity.
P2860
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
@ast
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
@en
type
label
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
@ast
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
@en
prefLabel
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
@ast
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
@en
P2093
P2860
P356
P1476
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
@en
P2093
Elsa Hansen
Jianhong Wu
Julien Arino
Seyed M Moghadas
P2860
P304
P356
10.1155/2010/690654
P407
P50
P577
2010-01-01T00:00:00Z